A fusion gene is a hybrid gene formed from two previously separate genes. It can occur as a result of: translocation, interstitial deletion, or chromosomal inversion. This occurs when a chromosomal break brings two separate genes together into a new functioning gene.
So far, the research has focused on protein-coded fusion genes. However, human genes consist not only of protein-coded components but also of components that lack this ability. The latter have not attracted any interest so far, argues Carlos Rovira, cancer researcher and associate professor of oncology at Lund University.
Topical Treatment Strategy Best to Treat Skin Cancer
To treat skin cancer, researchers are testing a technique in mice that combines low-intensity electric current with a formulation containing nanoencapsulated chemotherapy.
Advertisement
‘Fusion genes may occur naturally in the body by transfer of DNA between chromosomes. They have also been used for many years for targeted cancer treatment.’
Tweet it Now
"We study genes that lack the ability to produce proteins, and we were very surprised to discover that this type of study has not been done before - the 'non-coding' components of fusion genes have never been analysed globally in this context. This means that previous analyses have ruled out important genetic components, and that fusion gene data should be re-analysed to possibly find more markers and potential targets for cancer treatment", says Carlos Rovira, who has been researching breast cancer for many years.
So what have the researchers discovered?
"In our study, we discovered a new class of fusion genes that primarily affect the activity of microRNA. These genes are small and often located inside larger protein-coded genes, but they are very short and lack the code required to control protein production. It has already been shown that microRNAs are important for the development of cancer, but the relationship between them and fusion genes was previously unexplored."
![CRISPR Engineered Leukemia Models for Cancer Research]( "CRISPR Engineered Leukemia Models for Cancer Research")
Study uses multiplex CRISPR-Cas9 technology to edit human hematopoietic cells to generate cancer models.
Fusion genes are commonly found in patients with leukaemia and soft tissue cancers, and are of great value in terms of diagnosis and treatment. They have also been used for many years for targeted cancer treatment.
The next step will be to study fusion genes in other types of cancer, and see whether a similar discovery can be made in those contexts. "If we receive resources, we will study other types of cancer. It could become a goldmine for new diagnostics and, hopefully, new treatments", says Carlos Rovira.
In the present study, the researchers have collaborated with experts on chromosomal breakage and fusion genes Mattias Höglund, Felix Mitelman and Fredrik Mertens, as well as researcher Helena Persson who analysed the data. Their study includes breast cancer patients from 1 553 patients participating in the major SCAN-B project (Sweden Cancerome Analysis Network - Breast) led by Åke Borg.
Source: Eurekalert
"In our study, we discovered a new class of fusion genes that primarily affect the activity of microRNA. These genes are small and often located inside larger protein-coded genes, but they are very short and lack the code required to control protein production. It has already been shown that microRNAs are important for the development of cancer, but the relationship between them and fusion genes was previously unexplored."
CRISPR Engineered Leukemia Models for Cancer Research
Study uses multiplex CRISPR-Cas9 technology to edit human hematopoietic cells to generate cancer models.
Advertisement
Fusion genes are commonly found in patients with leukaemia and soft tissue cancers, and are of great value in terms of diagnosis and treatment. They have also been used for many years for targeted cancer treatment.
The next step will be to study fusion genes in other types of cancer, and see whether a similar discovery can be made in those contexts. "If we receive resources, we will study other types of cancer. It could become a goldmine for new diagnostics and, hopefully, new treatments", says Carlos Rovira.
In the present study, the researchers have collaborated with experts on chromosomal breakage and fusion genes Mattias Höglund, Felix Mitelman and Fredrik Mertens, as well as researcher Helena Persson who analysed the data. Their study includes breast cancer patients from 1 553 patients participating in the major SCAN-B project (Sweden Cancerome Analysis Network - Breast) led by Åke Borg.
Source: Eurekalert
Sperm Stem Cells Help Better Understand Infertility and Certain Cancers in Men
Male infertility and the risk of developing cancers like testicular and prostate cancer can be understood better by understanding the development of human sperm stem cells.
Advertisement
 Alcohol Aversion Drug Can Treat Chemo-resistant Lung CancerChemotherapy resistance can be reversed in non-small cell lung cancer (NSCLC) when combined with a well-known drug called Disulfiram. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
